Together, these findings suggest that the therapeutic spectrum of these IL-6-signaling targeting agents may be extended to preventing tumor metastasis, although the therapeutic use of these biological agents for cancer intervention remains to be evaluated and optimized [28,50]. This evidence concerns the gene IL6 and neoplasm.